Remedial effect of lupeol and its ester derivative on hypercholesterolemia-induced oxidative and inflammatory stresses

Nutrition Research

Volumn 27, Issue 12, 2007, Pages 778-787

  Sudhahar, Varatharajan ^a   Kumar, Sekar Ashok ^a   Mythili, Yenjerla ^a   Varalakshmi, Palaninathan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

High cholesterol diet; Nitrosative stress; Oxidative stress; Pentacyclic triterpene; Rats

Indexed keywords

CHOLESTEROL; CHOLIC ACID; ESTER DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LUPEOL; LUPEOL LINOLEATE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS;

EID: 36348964302     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.09.012     Document Type: Article

References (52)

1. Stefanogiannis N., Lawes C.M., Turley M., Tobias M., Hoorn S.V., Mhurchu C.N., et al. Nutrition and the burden of disease in New Zealand: 1997-2011. Public Health Nutr 8 (2005) 395-401
2. Krauss R.M., Winston M., Fletcher B.J., and Grundy S.M. Obesity: impact on cardiovascular disease. Circulation 98 (1998) 1472-1476
3. Kannel W.B., Castelli W.P., Gordon T., and McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74 (1971) 1-12
4. Prasad K., and Kalra J. Experimental atherosclerosis and oxygen free radicals. Angiology 40 (1989) 835-843
5. Han S.N., Leka L.S., Lichtenstein A.H., Ausman L.M., Schaefer E.J., and Meydani S.N. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 43 (2002) 445-452
6. Brand K., Eisele T., Kreusel U., Page M., Page S., Haas M., et al. Dysregulation of monocytic nuclear factor-kappa B by oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 17 (1997) 1901-1909
7. Swantek J.L., Christerson L., and Cobb M.H. Lipopolysaccharide-induced tumor necrosis factor-alpha promoter activity is inhibitor of nuclear factor-kappaB kinase-dependent. J Biol Chem 274 (1999) 11667-11671
8. Cogswell J.P., Godlevski M.M., Wisely G.B., Clay W.C., Leesnitzer L.M., Ways J.P., et al. NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immunol 153 (1994) 712-723
9. Saadeddin S.M., Habbab M.A., and Ferns G.A. Markers of inflammation and coronary artery disease. Med Sci Monit 8 (2002) RA5-RA12
10. Naka M., Nanbu T., Kobayashi K., Kamanaka Y., Komeno M., Yanase R., et al. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative. Biochem Biophys Res Commun 270 (2000) 663-667
11. Porsti I., and Paakkari I. Nitric oxide-based possibilities for pharmacotherapy. Ann Med 27 (1995) 407-420
12. Becquet F., Courtois Y., and Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Ophthalmol 42 (1997) 71-82
13. Dusting G.J. Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial reperfusion, and heart failure. EXS 76 (1996) 33-55
14. Kim Y.M., Lee B.S., Yi K.Y., and Paik S.G. Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 236 (1997) 655-660
15. Geetha T., and Varalakshmi P. Anti-inflammatory activity of lupeol linoleate in adjuvant induced arthritis. Fitoterapia 69 (1998) 13-19
16. Sunitha S., Nagaraj M., and Varalakshmi P. Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defence system in cadmium-induced hepatotoxicity in rats. Fitoterapia 72 (2001) 516-523
17. Somova L.I., Shode F.O., Ramnanan A., and Nadar A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J Ethnopharmacol 84 (2003) 299-305
18. Fernandez M.A., de las Heras B., Garcia M.D., Saenz M.T., and Villar A. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. J Pharm Pharmacol 53 (2001) 1533-1539
19. Sudhahar V., Kumar S.A., and Varalakshmi P. Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Life Sci 78 (2006) 1329-1335
20. Baskar R., Malini M.M., Varalakshmi P., Balakrishna K., and Bhima B. Effect of lupeol isolated from Crataeva nurvala stem bark against free radical-induced toxicity in experimental urolithiasis. Fitoterapia 67 (1996) 121-126
21. Balkan J., Kanbagli O., Hatipoglu A., Kucuk M., Cevikbas U., Aykac-Toker G., et al. Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem 66 (2002) 1755-1758
22. Shinnick F.L., Ink S.L., and Marlett J.A. Dose response to a dietary oat bran fraction in cholesterol-fed rats. J Nutr 120 (1990) 561-568
23. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5 (1992) 227-231
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
25. Sedlak J., and Lindsay R.H. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissues with Ellman's reagent. Anal Biochem 25 (1968) 192-205
26. Grilli A., De Lutiis M.A., Patruno A., Speranza L., Cataldi A., Centurione L., et al. Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue. Exp Biol Med (Maywood) 228 (2003) 935-942
27. Sudhahar V., Kumar S.A., Varalakshmi P., and Sundarapandiyan R. Mitigating role of lupeol and lupeol linoleate on hepatic lipemic-oxidative injury and lipoprotein peroxidation in experimental hypercholesterolemia. Mol Cell Biochem 295 (2007) 189-198
28. Gross S.S., and Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57 (1995) 737-769
29. Drexler H., and Zeiher A.M. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension 18 (1991) II90-II99
30. Moriel P., Pereira I.R., Bertolami M.C., and Abdalla D.S. Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia?. Free Radic Biol Med 30 (2001) 318-326
31. Takenaka Y., Miki M., Yasuda H., and Mino M. The effect of alpha-tocopherol as an antioxidant on the oxidation of membrane protein thiols induced by free radicals generated in different sites. Arch Biochem Biophys 285 (1991) 344-350
32. Cooper A.J., and Kristal B.S. Multiple roles of glutathione in the central nervous system. Biol Chem 378 (1997) 793-802
33. Yamashita K., Lu H., Lu J., Chen G., Yokoyama T., Sagara Y., et al. Effect of three triterpenoids, lupeol, betulin, and betulinic acid on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophils. Clin Chim Acta 325 (2002) 91-96
34. Wilson S.H., Caplice N.M., Simari R.D., Holmes Jr. D.R., Carlson P.J., and Lerman A. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis 148 (2000) 23-30
35. Barath P., Fishbein M.C., Cao J., Berenson J., Helfant R.H., and Forrester J.S. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 137 (1990) 503-509
36. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
37. Cybulsky M.I., and Gimbrone Jr. M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251 (1991) 788-791
38. Cominacini L., Garbin U., Pasini A.F., Davoli A., Campagnola M., Pastorino A.M., et al. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. J Hypertens 16 (1998) 1913-1919
39. de las Heras B., Navarro A., Diaz-Guerra M.J., Bermejo P., Castrillo A., Bosca L., et al. Inhibition of NOS-2 expression in macrophages through the inactivation of NF-kappa B by andalusol. Br J Pharmacol 128 (1999) 605-612
40. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., et al. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 58 (1998) 717-723
41. Hallenbeck J.M., Dutka A.J., Vogel S.N., Heldman E., Doron D.A., and Feuerstein G. Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke. Brain Res 541 (1991) 115-120
42. Mantovani A. The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment. Drugs 54 (1997) 15-23
43. Castell J.V., Andus T., Kunz D., and Heinrich P.C. Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann NY Acad Sci 557 (1989) 87-99
44. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
45. Bullo M., Garcia-Lorda P., Megias I., and Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11 (2003) 525-531
46. Libby P., and Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 100 (1999) 1148-1150
47. Goldstein I.M., Ostwald P., and Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res 36 (1996) 2979-2994
48. Kubes P., and McCafferty D.M. Nitric oxide and intestinal inflammation. Am J Med 109 (2000) 150-158
49. Xie Q.W., Whisnant R., and Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177 (1993) 1779-1784
50. Aliev G., Shi J., Perry G., Friedland R.P., and Lamanna J.C. Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet. Anat Rec 260 (2000) 16-25
51. Harrison D.G. Endothelial control of vasomotion and nitric oxide production: a potential target for risk factor management. Cardiol Clin 14 (1996) 1-15
52. Nikiema J.B., Vanhaelen-Fastre R., Vanhaelen M., Fontaine J., De Graef C., and Heenen M. Effects of antiinflammatory triterpenes isolated from Leptadenia hastata latex on keratinocyte proliferation. Phytother Res 15 (2001) 131-134